Skip to main content
. 2022 Mar 25;41(2):136–149. doi: 10.23876/j.krcp.22.001

Figure 1. The mechanisms underlying the nephroprotective effects of GLP-1 receptor agonists.

Figure 1.

GLP-1, glucagon-like peptide 1.